Issues in the Use of Stepped Wedge Cluster and Alternative Designs in the Case of Pandemics

American Journal of Bioethics

Volumn 13, Issue 9, 2013, Pages 23-24

  van der Tweel, Ingeborg ^a   van der Graaf, Rieke ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ARTICLE; DRUG DEVELOPMENT; ETHICS; HUMAN; HUMAN EXPERIMENT; LEGAL ASPECT; MEDICAL RESEARCH; PANDEMIC; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS;

BIOMEDICAL RESEARCH; DRUG DISCOVERY; DRUGS, INVESTIGATIONAL; ETHICS, RESEARCH; HUMANS; PANDEMICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THERAPEUTIC HUMAN EXPERIMENTATION;

EID: 84883468064     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2013.813603     Document Type: Article

References (11)

1. Edwards, S. J. L. 2013. Ethics of clinical science in a public health emergency: Drug discovery at the bedside. American Journal of Bioethics, 13 (9): 3 - 14.
2. Friedman, L. M., Furberg, C. D. and DeMets, D. L. 2010. Fundamentals of clinical trials, 4th ed., New York, NY: Springer.
3. Hussey, M. A. and Hughes, J. P. 2007. Design and analysis of stepped wedge cluster randomized trials. Contemporary Clinical Trials, 28 (2): 182 - 191. doi: 10.1016/j.cct.2006.05.007
4. Koch, A. 2006. Confirmatory clinical trials with an adaptive design. Biometrical Journal.Biometrische Zeitschrift, 48 (4): 574 - 585.
5. Kotz, D., Spigt, M., Arts, I. C., Crutzen, R. and Viechtbauer, W. 2012a. Use of the stepped wedge design cannot be recommended: A critical appraisal and comparison with the classic cluster randomized controlled trial design. Journal of Clinical Epidemiology, 65 (12): 1249 - 1252. doi: 10.1016/j.jclinepi.2012.06.004; 10.1016/j.jclinepi.2012.06.004
6. Kotz, D., Spigt, M., Arts, I. C., Crutzen, R. and Viechtbauer, W. 2012b. Researchers should convince policy makers to perform a classic cluster randomized controlled trial instead of a stepped wedge design when an intervention is rolled out. Journal of Clinical Epidemiology, 65 (12): 1255 - 1256. doi: 10.1016/j.jclinepi.2012.06.016; 10.1016/j.jclinepi.2012.06.016
7. Mdege, N. D., Man, M. S. M. S., Taylor Nee Brown, C. A. and Torgerson, D. J. 2011. Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation. Journal of Clinical Epidemiology, 64 (9): 936 - 948. doi: 10.1016/j.jclinepi.2010.12.003
8. Muller, M. P., McGeer, A., Straus, S. E., Hawryluck, L. and Gold, W. L. 2004. Clinical trials and novel pathogens: Lessons learned from SARS. Emerging Infectious Diseases [serial online] March. Available at: http://www.cdc.gov/ncidod/EID/vol10no3/03-0702.htm
9. Van der Tweel, I and Bollen, C. W. 2010. Sequential meta-analysis: An efficient decision-making tool. Clinical Trials, 7: 136 - 146.
10. Whitehead, A. 1997. A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Statistics in Medicine, 16: 2901 - 2913.
11. Whitehead, J. 1997. The design and analysis of sequential clinical trials, Chichester, UK: Wiley.